News

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

CITY

Rich pickings: Many in the City of London are fretting about the lack of inward investment, but if there is one financial British product North Americans cannot get enough of it’s pensions, says Liam

Out of puff: Second-quarter revenue at Connecticut-based Marlboro-maker Philip Morris International (PMI) rose 7.1% from a year earlier, to $10.1bn – slightly short of analysts’ expectations of $10.3b

Issue of the week: populism and central banks ...

Companies in the news and how they were assessed